当前位置:
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Editorial: Are glucagon‐like peptide‐1 receptor agonists the functional cure for patients with metabolic dysfunction‐associated cirrhosis?
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2024-04-23 , DOI: 10.1111/apt.17943 Elton Dajti 1, 2 , Susana G. Rodrigues 3
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2024-04-23 , DOI: 10.1111/apt.17943 Elton Dajti 1, 2 , Susana G. Rodrigues 3
Affiliation
LINKED CONTENTThis article is linked to Elsaid et al paper. To view this article, visit https://doi.org/10.1111/apt.17925
中文翻译:
社论:胰高血糖素样肽-1 受体激动剂是代谢功能障碍相关肝硬化患者的功能性治愈方法吗?
链接内容本文链接到 Elsaid 等人的论文。要查看这篇文章,请访问https://doi.org/10.1111/apt.17925
更新日期:2024-04-23
中文翻译:
社论:胰高血糖素样肽-1 受体激动剂是代谢功能障碍相关肝硬化患者的功能性治愈方法吗?
链接内容本文链接到 Elsaid 等人的论文。要查看这篇文章,请访问